Mental Health Medication Recalls
Recalls of antidepressants, anti-anxiety and related psychiatric medications.
226 recalls in this category, newest first.
Class III · Low risk Terminated Feb 27, 2020
Reason Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate…
Class III · Low risk Terminated Feb 27, 2020
Reason Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate…
Class II · Moderate risk Terminated Oct 23, 2019
Reason Presence of Foreign Substance
Class III · Low risk Terminated Feb 28, 2019
Reason Failed Dissolution Specifications; 9-monthstability timepoint
Class II · Moderate risk Terminated Jan 18, 2019
Reason Failed Impurities/Degradation Specifications: Elevated levels of a known impurity detected during 6-month RT stability interval.
Class II · Moderate risk Terminated Nov 14, 2018
Reason Presence of Foreign Substance; metal shard found in tablet
Class III · Low risk Terminated Oct 5, 2018
Reason Container packaging defect.
Class II · Moderate risk Terminated Sep 20, 2018
Reason Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.
Class III · Low risk Terminated Sep 6, 2018
Reason Failed impurities/ degradation specifications: Out-of-specification results were observed in the meta-chlorobenzoic acid impurity in batches 18…
Class III · Low risk Terminated Aug 9, 2018
Reason Defective Container: Customer complaints of punctures in the bottle.
Class III · Low risk Terminated Mar 15, 2018
Reason Failed Dissolution Specifications; during stability testing
Class III · Low risk Terminated Mar 15, 2018
Reason Failed Dissolution Specifications; during stability testing
Class II · Moderate risk Terminated Feb 9, 2018
Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure…
Class III · Low risk Terminated Feb 5, 2018
Reason Failed impurities/ degradation specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling all lots within expiry due to out of…
Class III · Low risk Terminated Feb 5, 2018
Reason Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted from the product carton, primary label is…
Class III · Low risk Terminated Nov 21, 2017
Reason Failed Dissolution Specification
Class II · Moderate risk Terminated Oct 20, 2017
Reason SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Class II · Moderate risk Terminated Oct 6, 2017
Reason Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
Class II · Moderate risk Terminated Sep 26, 2017
Reason Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.
Class II · Moderate risk Terminated Jun 1, 2017
Reason Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Class III · Low risk Terminated May 30, 2017
Reason Failed Moisture Limits: Product tested out-of-specification for moisture content.
Class II · Moderate risk Terminated Dec 22, 2016
Reason Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.
Class III · Low risk Terminated Dec 20, 2016
Reason Failed Dissolution Specifications; 18 month stability time point
Class III · Low risk Terminated Dec 20, 2016
Reason Failed Dissolution Specifications; 18 month stability time point
Class III · Low risk Terminated Nov 2, 2016
Reason Failed Dissolution Specifications; 6 month time point